Longitudinal surveillance and combination antimicrobial susceptibility testing of multi-drug resistant R Achromobacter Spp. from cystic fibrosis patients: Supplemental data

  • Ijeoma Okoliegbe (NHS Grampian) (Creator)
  • Karolin Hijazi (Creator)
  • Kim Cooper (Creator)
  • Corinne Ironside (Creator)
  • Ian Gould (Creator)



Contains information on the study demographics, minimum inhibitory concentration and synergy combinations for antimicrobials.

Data type

Excel file
Date made available2 Jan 2020
PublisherUniversity of Aberdeen
Date of data production29 Jun 2020

Cite this